MedTrace Logo

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

NCT03710616 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2019-08-01

No results posted yet for this study

Summary

The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.

Conditions

Interventions

PROCEDURE

Surgeries

Surgical operations plus systematic lymphadenectomies

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • Wenhua LIANG, Ph.D · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-24
Primary Completion
2022-12-30
Completion
2023-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710616 on ClinicalTrials.gov